Kalirin is Under-Expressed in Alzheimer's Disease Hippocampus
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
To identify genes aberrantly expressed in the brain of individuals with Alzheimer's Disease (AD), we analyzed RNA extracts from the hippocampus and cerebellum from 19 AD patients and 15 age- and sex-matched control subjects. Our analysis identified a number of genes that were over-expressed or under-expressed specifically in AD hippocampus. Among these genes, kalirin was the most consistently under-expressed in AD hippocampus, which was verified by semi-quantitative RT-PCR and real time PCR. Kalirin is predominantly expressed in the brain, particularly in the hippocampus, and plays crucial roles in neuronal stability and growth. Our observation is the first to relate kalirin to AD and a human disease. In addition to kalirin, the genes for voltage-gated Ca++ channel gamma subunit 3 and visinin-like protein 1 (a Ca++ sensor protein) were under-expressed, whereas inositol 1,4,5-triphosphate 3-kinase B was over-expressed in AD hippocampus. Collectively, these differential expressions could severely impair calcium homeostasis. Remarkably, these aberrant gene expressions in AD hippocampus were not observed in AD cerebellum. Furthermore, housekeeping genes such as ribosomal protein genes are not affected by AD. These results provide new insights into the biochemistry of AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, mRNA and protein levels of kalirin-7, a key regulator of spine morphogenesis and an upstream activator of PAK in spines, were found to be substantially diminished in the hippocampus of individuals with Alzheimer’s disease71,72, suggesting a role for the kalirin-7–Rac1–PAK pathway in Alzheimer’s disease–associated spine pathology.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [72]
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168 · cited 1×
“5 million people in the United States [20].”
BackgroundHYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542
The metallobiology of Alzheimer's disease
Bush, A. I. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00067-5 · Cited by 1,315
Hakak, Y., Walker, J. R., Li, C., Wong, W. H., Davis, K. L., Buxbaum, J. D., Haroutunian, V., & Fienberg, A. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081071198 · Cited by 1,192
Butterfield, D. A., & Lauderback, C. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00794-3 · Cited by 1,001
Alzheimer's Disease: Molecular Understanding Predicts Amyloid-Based Therapeutics
Selkoe, D. J., & Schenk, D. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140248 · Cited by 818
Discovering statistically significant pathways in expression profiling studies
Tian, L., Greenberg, S. A., Kong, S. W., Altschuler, J., Kohane, I. S., & Park, P. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506577102 · Cited by 648
de Kok, J. B., Roelofs, R. W., Giesendorf, B. A., Pennings, J. L., Waas, E. T., Feuth, T., Swinkels, D. W., & Span, P. N. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700208 · Cited by 580
Colangelo, V., Schurr, J., Ball, M. J., Pelaez, R. P., Bazan, N. G., & Lukiw, W. J. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10351 · Cited by 517
Cited by
Dendritic spine pathology in neuropsychiatric disorders
Penzes, P., Cahill, M. E., Jones, K. A., VanLeeuwen, J.-E., & Woolfrey, K. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2741 · Cited by 1,523
Dendritic Spines: The Locus of Structural and Functional Plasticity
Sala, C., & Segal, M. (2014) · Physiological Reviews · doi:10.1152/physrev.00012.2013 · Cited by 465
Rho family GTPases: Key players in neuronal development, neuronal survival, and neurodegeneration
Stankiewicz, T. R., & Linseman, D. A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00314 · Cited by 391
Lin, Y.-C., & Koleske, A. J. (2010) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-060909-153204 · Cited by 248
Gene expression profiling in human neurodegenerative disease
Cooper-Knock, J., Kirby, J., Ferraiuolo, L., Heath, P. R., Rattray, M., & Shaw, P. J. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.156 · Cited by 223
Borovac, J., Bosch, M., & Okamoto, K. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.07.001 · Cited by 179
Kalirin regulates cortical spine morphogenesis and disease-related behavioral phenotypes
Cahill, M. E., Xie, Z., Day, M., Photowala, H., Barbolina, M. V., Miller, C. A., Weiss, C., Radulovic, J., Sweatt, J. D., Disterhoft, J. F., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904636106 · Cited by 170
“KALRN mRNA and kalirin protein expression are consistently underexpressed in the forebrain of Alzheimer’s disease patients (15, 16).”
BackgroundKalirin-7 Is Required for Synaptic Structure and Function
Ma, X.-M., Kiraly, D. D., Gaier, E. D., Wang, Y., Kim, E.-J., Levine, E. S., Eipper, B. A., & Mains, R. E. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4269-08.2008 · Cited by 168
Dendritic spine dynamics--a key role for kalirin-7
Penzes, P., & Jones, K. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.001 · Cited by 157
Gómez Ravetti, M., Rosso, O. A., Berretta, R., & Moscato, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010153 · Cited by 140
Convergent CaMK and RacGEF signals control dendritic structure and function
Penzes, P., Cahill, M. E., Jones, K. A., & Srivastava, D. P. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.07.002 · Cited by 131
Impaired regulation of synaptic actin cytoskeleton in Alzheimer's disease
Penzes, P., & VanLeeuwen, J. (2011) · Brain Research Reviews · doi:10.1016/j.brainresrev.2011.01.003 · Cited by 131
Cissé, M., Duplan, E., Lorivel, T., Dunys, J., Bauer, C., Meckler, X., Gerakis, Y., Lauritzen, I., & Checler, F. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.152 · Cited by 108
An autism spectrum disorder-related de novo mutation hotspot discovered in the GEF1 domain of Trio
Sadybekov, A., Tian, C., Arnesano, C., Katritch, V., & Herring, B. E. (2017) · Nature Communications · doi:10.1038/s41467-017-00472-0 · Cited by 112
Endoplasmic reticulum calcium stores in dendritic spines
Segal, M., & Korkotian, E. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00064 · Cited by 86
Neuronal Rho GEFs in Synaptic Physiology and Behavior
Miller, M. B., Yan, Y., Eipper, B. A., & Mains, R. E. (2013) · The Neuroscientist · doi:10.1177/1073858413475486 · Cited by 74
Kalirin, a Key Player in Synapse Formation, Is Implicated in Human Diseases
Mandela, P., & Ma, X.-M. (2012) · Neural Plasticity · doi:10.1155/2012/728161 · Cited by 63
The visinin-like proteins VILIP-1 and VILIP-3 in Alzheimer’s disease—old wine in new bottles
Braunewell, K. H. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00020 · Cited by 66
β-Amyloid 42/40 ratio and kalirin expression in Alzheimer disease with psychosis
Murray, P. S., Kirkwood, C. M., Gray, M. C., Ikonomovic, M. D., Paljug, W. R., Abrahamson, E. E., Henteleff, R. A., Hamilton, R. L., Kofler, J. K., Klunk, W. E., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.02.015 · Cited by 54
Deconstructing signal transduction pathways that regulate the actin cytoskeleton in dendritic spines
Penzes, P., & Cahill, M. E. (2012) · Cytoskeleton · doi:10.1002/cm.21015 · Cited by 64
Niftullayev, S., & Lamarche‐Vane, N. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061497 · Cited by 60
Cross-talk between redox signalling and protein aggregation
van Dam, L., & Dansen, T. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190054 · Cited by 47
Kalirin: a novel genetic risk factor for ischemic stroke
Krug, T., Manso, H., Gouveia, L. O., Sobral, J., Xavier, J. M., Albergaria, I., Gaspar, G., Correia, M. A., Baptista, M. V., Simões, R. M., et al. (2010) · Human Genetics · doi:10.1007/s00439-010-0790-y · Cited by 58
Kalirin and Trio: RhoGEFs in Synaptic Transmission, Plasticity, and Complex Brain Disorders
Paskus, J. D., Herring, B. E., & Roche, K. W. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.05.002 · Cited by 58
Kalirin loss results in cortical morphological alterations
Xie, Z., Cahill, M. E., & Penzes, P. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.09.006 · Cited by 56
The Role of Visinin-Like Protein-1 in the Pathophysiology of Alzheimer’s Disease
Groblewska, M., Muszyński, P., Wojtulewska-Supron, A., Kulczyńska-Przybik, A., & Mroczko, B. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-150060 · Cited by 51
Eph receptors: New players in Alzheimer's disease pathogenesis
Cissé, M., & Checler, F. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.028 · Cited by 46
A role for Kalirin-7 in corticostriatal synaptic dysfunction in Huntington's disease
Puigdellívol, M., Cherubini, M., Brito, V., Giralt, A., Suelves, N., Ballesteros, J. J., Zamora‐Moratalla, A., Martín, E. D., Eipper, B. A., Alberch, J., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv426 · Cited by 52
KALRN: A central regulator of synaptic function and synaptopathies
Parnell, E., Shapiro, L. P., Voorn, R. A., Forrest, M. P., Jalloul, H. A., Loizzo, D. D., & Penzes, P. (2020) · Gene · doi:10.1016/j.gene.2020.145306 · Cited by 52
Pharmacological Modulators of Small GTPases of Rho Family in Neurodegenerative Diseases
Guiler, W., Koehler, A., Boykin, C., & Lu, Q. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.661612 · Cited by 51
The Role of Ephs and Ephrins in Memory Formation
Dines, M., & Lamprecht, R. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv106 · Cited by 47
Abnormal kalirin signaling in neuropsychiatric disorders
Remmers, C., Sweet, R. A., & Penzes, P. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.12.006 · Cited by 42
Somatic Signature of Brain-Specific Single Nucleotide Variations in Sporadic Alzheimer's Disease
Parcerisas, A., Rubio, S. E., Muhaisen, A., Gómez-Ramos, A., Pujadas, L., Puiggros, M., Rossi, D., Ureña, J., Burgaya, F., Pascual, M., et al. (2014) · Journal of Alzheimer’s Disease · doi:10.3233/jad-140891 · Cited by 44
Kalirin Signaling: Implications for Synaptic Pathology
Penzes, P., & Remmers, C. L. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8223-z · Cited by 44
Arefin, A. S., Mathieson, L., Johnstone, D. M., Berretta, R. E., & Moscato, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045535 · Cited by 43
Roles of Calcium Stores and Store-Operated Channels in Plasticity of Dendritic Spines
Segal, M., & Korkotian, E. (2015) · The Neuroscientist · doi:10.1177/1073858415613277 · Cited by 43
Kalrn promoter usage and isoform expression respond to chronic cocaine exposure
Mains, R. E., Kiraly, D. D., Eipper-Mains, J. E., Ma, X., & Eipper, B. A. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-20 · Cited by 42
Bircher, J. E., & Koleske, A. J. (2021) · Journal of Cell Science · doi:10.1242/jcs.248393 · Cited by 41
Bai, Y., Xiang, X., Liang, C., & Shi, L. (2015) · BioMed Research International · doi:10.1155/2015/632450 · Cited by 40
Ma, X., Miller, M. B., Vishwanatha, K. S., Gross, M. J., Wang, Y., Abbott, T. B., Lam, T. T., Mains, R. E., & Eipper, B. A. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-04-0215 · Cited by 38
Hosseinian, S., Arefian, E., Rakhsh-Khorshid, H., Eivani, M., Rezayof, A., Pezeshk, H., & Marashi, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-64452-z · Cited by 37
Winkler, J. M., & Fox, H. S. (2013) · BMC Systems Biology · doi:10.1186/1752-0509-7-51 · Cited by 35
Hippocampal phenotypes in kalirin-deficient mice
Xie, Z., Cahill, M. E., Radulovic, J., Wang, J., Campbell, S. L., Miller, C. A., Sweatt, J. D., & Penzes, P. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.08.005 · Cited by 34
“Analysis of postmortem brain tissue found that in human subjects with Alzheimer's disease kalirin mRNA and protein were consistently underexpressed (Youn et al., 2007a).”
BackgroundImplication of Rho GTPases in Neurodegenerative Diseases
Antoine-Bertrand, J., Villemure, J.-F., & Lamarche-Vane, N. (2011) · Current Drug Targets · doi:10.2174/138945011795906543 · Cited by 31
Tamnanloo, F., Ochoa‐Sanchez, R., Oliveira, M. M., Lima, C., Lépine, M., Dubois, K., Bosoi, C. R., Tremblay, M., Sleno, L., & Rose, C. F. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100904 · Cited by 29
Kalirin-7, a Protein Enriched in Postsynaptic Density, is Involved in Ischemic Signal Transduction
Beresewicz, M., Kowalczyk, J. E., & Zabłocka, B. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9631-y · Cited by 28
Identification of Kalirin-7 as a Potential Post-Synaptic Density Signaling Hub
Kiraly, D. D., Stone, K. L., Colangelo, C. M., Abbott, T., Wang, Y., Mains, R. E., & Eipper, B. A. (2011) · Journal of Proteome Research · doi:10.1021/pr200088w · Cited by 26
Liebl, M. P., Kaya, A. M., Tenzer, S., Mittenzwei, R., Koziollek‐Drechsler, I., Schild, H., Moosmann, B., Behl, C., & Clement, A. M. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.04.008 · Cited by 27
Makrythanasis, P., Guipponi, M., Santoni, F. A., Zaki, M. S., Issa, M. Y., Ansar, M., Hamamy, H., & Antonarakis, S. E. (2016) · Human Genomics · doi:10.1186/s40246-016-0082-2 · Cited by 22
Mandela, P., Yan, Y., LaRese, T. P., Eipper, B. A., & Mains, R. E. (2014) · Hormones and Behavior · doi:10.1016/j.yhbeh.2014.07.001 · Cited by 21
Lefort, R. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0328-4 · Cited by 17
Trio preserves motor synapses and prolongs motor ability during aging
Banerjee, S., Vernon, S. W., Ruchti, E., Limoni, G., Jiao, W., Asadzadeh, J., Campenhoudt, M. V., & McCabe, B. D. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114256 · Cited by 17
Kalirin‐7 prevents dendritic spine dysgenesis induced by amyloid beta‐derived oligomers
Xie, Z., Shapiro, L. P., Cahill, M. E., Russell, T. A., Lacor, P. N., Klein, W. L., & Penzes, P. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14311 · Cited by 17
Kalirin-7 is a Key Player in the Formation of Excitatory Synapses in Hippocampal Neurons
Ma, X. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.148 · Cited by 17
Long‐term perturbation of spine plasticity results in distinct impairments of cognitive function
VanLeeuwen, J., & Penzes, P. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07899.x · Cited by 15
Russo-Savage, L., Rao, V. K. S., Eipper, B. A., & Mains, R. E. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.07.006 · Cited by 12
Distinct effects of SDC3 and FGFRL1 on selective neurodegeneration in AD and PD
Wang, J., Chen, P., Hu, B., Cai, F., Xu, Q., Pan, S., Wu, Y., & Song, W. (2023) · The FASEB Journal · doi:10.1096/fj.202201359r · Cited by 11
LaRese, T. P., Yan, Y., Eipper, B. A., & Mains, R. E. (2017) · BMC Neuroscience · doi:10.1186/s12868-017-0363-2 · Cited by 9
Age‐dependent increase in Kalirin‐9 and Kalirin‐12 transcripts in human orbitofrontal cortex
Grubisha, M. J., Lin, C., Tseng, G. C., Penzes, P., Sibille, E. L., & Sweet, R. A. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13351 · Cited by 8
Quiccione, M. S., Tirozzi, A., Cassioli, G., Morelli, M., Costanzo, S., Pepe, A., Bracone, F., Magnacca, S., Cerletti, C., Licastro, D., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910317 · Cited by 7
Singh, H. N., Swarup, V., Dubey, N. K., Jha, N. K., Singh, A. K., Lo, W., & Kumar, S. (2022) · Biomedicines · doi:10.3390/biomedicines10030611 · Cited by 7
Hu, B.-Q., Chen, R., Zhang, D.-X., Jiang, G., & Pang, C.-Y. (2012) · IEEE International Conference on Granular Computing (GrC) · doi:10.1109/grc.2012.6468612 · Cited by 7
Bankaitis, V. A., Khan, D., Chen, X., Wang, Y., & Igumenova, T. I. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2025.159625 · Cited by 4
Kwon, Y., Lee, S. J., Shin, Y. K., Choi, J.-S., Park, D. E., & Shin, J. E. (2025) · Animal Cells and Systems · doi:10.1080/19768354.2024.2448999 · Cited by 4
Gil, B., Sullivan, M., Scaife, C., Glennon, J. C., & Herron, C. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104944 · Cited by 3
Kaya, B., Orhan, M. E., Yanbul, S., Demirci, M. D. S., Demir, S. A., & Seyrantepe, V. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02395-8 · Cited by 2
Rebaud, S. (2015) · theses.fr (ABES) · doi:10.70675/9ea33832za5aaz4dcez822fz64e543bae8e6 · Cited by 2
Structural Alterations of Synapses in Psychiatric and Neurodegenerative Disorders
Penzes, P., Remmers, C. L., Cahill, M. E., Jones, K. A., VanLeeuwen, J., & Woolfrey, K. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418675-0.00009-2 · Cited by 1
GWAS with AHP based SNP prioritization approach to identify SNP biomarkers for Alzheimer's disease
Kadioglu, O., Üstünkar, G., & Son, Y. A. (2012) · International Symposium on Health Informatics and Bioinformatics (HIBIT) · doi:10.1109/hibit.2012.6209034 · Cited by 1
Screen for kinases affecting amyloidogenic cleavage by BACE1
Penzkofer, S. (2011) · KOPS (University of Konstanz) · Cited by 1
Stress réticulaire et maladie d'Alzheimer : contribution du facteur de transcription XBP-1s
Gerakis, Y. (2016) · theses.fr (ABES) · doi:10.70675/c0ee89fezec61z4295zbc26z2936720cadde · Cited by 1
Novel links between protein sorting and cytoskeletal dynamics in the secretory pathway
Prosser, D. C. (2008) · uO Research (University of Ottawa) · doi:10.20381/ruor-13013
Gaier, E. D. (2013) · OpenCommons - UConn (University of Connecticut)
Heaney, C. F. (2015) · Digital Scholarship - UNLV (University of Nevada Reno) · doi:10.34917/7645911
Ant Colony Optimization Vs Genetic Algorithm to Calculate Gene Order of Gene
Hu, B.-Q., Zhang, D.-X., Jiang, G., & Pang, Y. (2012)
Architecture génétique des troubles du spectre autistique dans les îles Féroé
Carton-Buonafine, C. (2018) · theses.fr (ABES) · doi:10.70675/dbe8347ez7174z46b8z977cz5e2d1e28fb19
Selective neurodegeneration in Alzheimer's disease and Parkinson's disease
Wang, J. (2017) · cIRcle (University of British Columbia) · doi:10.14288/1.0357032
Yeh, M. L., Yasko, J. R., Levine, E. S., Eipper, B. A., & Mains, R. E. (2020) · Research Square · doi:10.21203/rs.3.rs-41613/v1
권영희 (2019) · Seoul National University Open Repository (Seoul National University)
Yeh, M. L., Yasko, J. R., Levine, E. S., Eipper, B. A., & Mains, R. E. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/744508
Yeh, M. L., Yasko, J. R., Levine, E. S., Eipper, B. A., & Mains, R. E. (2020) · Research Square · doi:10.21203/rs.3.rs-41613/v2
Étude de la dysfonction du RhoGEF TRIO et son implication dans les troubles du neurodéveloppement
Bonnet, M. (2022) · theses.fr (ABES) · doi:10.70675/cab1f541zb97cz4ac7zb1fcz1abc79fd1066
Metadata
- Authors
- Youn, H., Jeoung, M., Koo, Y., Ji, H., Markesbery, W. R., Ji, I., & Ji, T. H.
- Affiliations
- University of Kentucky (US)
- Stanford Medicine (US)
- Corresponding author
- Ji, Tae H.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2007-05-29
- Volume
- 11
- Issue
- 3
- Pages
- 385-397
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W7362354
- Cited by
- 77
- References
- 31
- Citations by year
- 2025: 4 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 8 · 2019: 2 · 2018: 2 · 2017: 2 · 2016: 3 · 2015: 6 · 2014: 9 · 2013: 3 · 2012: 10
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Kentucky
- National Institutes of Health (5r01gm074101-03, 5r01hd018702-30)
- National Institute on Aging (P50AG005144, 5 P50 AG05144)
- National Institute of General Medical Sciences (R01 GM74101)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01 HD18702)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Kalirin, Alzheimer's disease
- MeSH terms
- Alzheimer Disease, Cerebellum, Female, Hippocampus, Humans, Male, RNA, Gene Expression, Protein Serine-Threonine Kinases, Reverse Transcriptase Polymerase Chain Reaction, Guanine Nucleotide Exchange Factors, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.